Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences
Male
Genotype
Incidence
Amyotrophic Lateral Sclerosis
Blotting, Western
DNA Mutational Analysis
Histocompatibility Antigens Class I
Membrane Proteins
Middle Aged
Cytoskeletal Proteins
Neuroblastoma
03 medical and health sciences
0302 clinical medicine
Gene Frequency
Case-Control Studies
Cell Line, Tumor
Mutation
Humans
Female
Age of Onset
Amino Acids
Hemochromatosis Protein
DOI:
10.1016/j.jns.2004.08.003
Publication Date:
2004-09-21T18:24:21Z
AUTHORS (7)
ABSTRACT
The etiology of amyotrophic lateral sclerosis (ALS) is unknown. The presence of mutations in the superoxide dismutase gene (SOD1) has led to theories regarding a role for oxidative stress in the pathogenesis of this disease. A primary cause of oxidative stress is perturbations in cellular iron homeostasis. Cellular iron mismanagement and oxidative stress are associated with a number of neurodegenerative diseases. One mechanism by which cells fail to properly regulate their iron status is through a mutation in the Hfe gene. Mutations in the Hfe gene are associated with the iron overload disease, hemochromatosis. In the current study, 31% of patients with sporadic ALS carried a mutation in the Hfe gene, compared to only 14% of patients without identifiable neuromuscular disease, or with neuromuscular diseases other than ALS (p<0.005). To determine the cellular consequences of carrying an Hfe mutation, a human neuronal cell line was transfected with genes carrying the Hfe mutation. The presence of the Hfe mutation disrupted expression of tubulin and actin at the protein levels potentially consistent with the disruption of axonal transport seen in ALS and was also associated with a decrease in CuZnSOD1 expression. These data provide compelling evidence for a role for the Hfe mutation in etiopathogenesis of ALS and warrant further investigation.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (34)
CITATIONS (94)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....